VIRAGEN
Viragen, together with its subsidiaries, engages in the research, development, manufacture, and commercialization of therapeutic proteins for the treatment of cancers and viral diseases in humans. Its product and product candidate portfolio includes Multiferon, a human alpha interferon product that comprise multiple subtype alpha interferons for the treatment of various infectious diseases and cancers; VG101 a therapeutic humanized monoclonal antibody targeting the treatment of malignant melanom... a; and VG102 a therapeutic humanized antibody designed for the treatment of various solid tumors. The company also develops Avian Transgenics technology for production of human therapeutic proteins and antibodies. It operates in the United States, Scotland, and Sweden. The company was founded in 1979 and is headquartered in Plantation, Florida.
VIRAGEN
Industry:
Biotechnology Manufacturing Therapeutics
Founded:
1979-01-01
Address:
Fort Lauderdale, Florida, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
9.43 M USD
Similar Organizations
Anika Therapeutics
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its
Choice Therapeutics
Choice Therapeutics develops, manufactures and commercializes medical devices for burns, advanced wound care, and surgical site infections.
GeneExcel
GeneExcel is engaged in the R&D and deployment of liposome technologies for the treatment of cancer, HIV, and cardiovascular diseases.
Investors List
RAB Capital
RAB Capital investment in Venture Round - Viragen
PEF Advisors
PEF Advisors investment in Venture Round - Viragen
More informations about "Viragen"
Viragen - Crunchbase Company Profile & Funding
Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.See details»
Viragen Inc - Company Profile and News - Bloomberg Markets
Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protien-based drugs designed to treat a broad …See details»
Viragen - Products, Competitors, Financials, Employees, …
Viragen is a Healthcare/Biotechnology company based in Plantation, Florida. Viragen's investors include Bristol Capital Advisors, Cantara, Alpha Capital Partners, PEF Advisors, Gryphon and …See details»
Viragen - Funding, Financials, Valuation & Investors - Crunchbase
Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.See details»
VIRAGEN, INC. - SEC.gov
Viragen is authorized to issue a total of 1,000,000 shares of preferred stock, par value $1.00 per share. Viragen’s board of directors may issue preferred stock by resolutions, without any …See details»
Viragen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.See details»
Viragen loses its fight for survival | The Herald - Herald Scotland
Oct 25, 2007 · Viragen, the cash-strapped Edinburgh cancer therapy researcher, has lost its battle for survival, declaring bankruptcy with more than $193m (£94m) in cumulative losses.See details»
Viragen, Inc. International Announces Plan to Optimize Capital ...
Jul 2, 2007 · PLANTATION, Fla., June 29 /PRNewswire-FirstCall/ -- Viragen International, Inc. , a majority-owned subsidiary of Viragen, Inc. , today announced that its Board of Directors and …See details»
Viragen Continues Restructuring To Sustain Remaining Resources
Mar 5, 2003 · Beyond Multiferon, Viragen had been working to develop protein-based drug candidates that include monoclonal antibodies, peptide drugs and therapeutic vaccines. …See details»
Viragen Reports Advancement in Avian Transgenics …
Feb 21, 2005 · Viragen, Inc. announced an advancement in its program to develop avian transgenic biomanufacturing for the purpose of using chickens as bioreactors for the efficient …See details»
CDMO Viralgen opens doors for AAV manufacturing - BioProcess …
Jul 2, 2021 · Viralgen has opened an $83 million AAV production site in San Sebastian, the first gene therapy production facility in Spain.See details»
Viralgen Announces Javier Garcia as Board Chairman and Jimmy …
Dec 22, 2022 · Viralgen is an independent and fully integrated Contract Development and Manufacturing Organization (CDMO) that produces AAV gene therapy treatments for the …See details»
Viragen - Crunchbase
Viragen researches, develops, manufactures and commercializes therapeutic proteins for the treatment of cancers and viral diseases.See details»
New 'Genesis' for Viragen's Anti-CD55 Cancer Program
Dec 17, 2010 · Failed biotech Viragen Inc. might have called it quits in 2007, but its monoclonal antibody targeting CD55 was reborn in start-up Genesis Biopharma Inc., which licensed the …See details»
Viralgen receives cGMP certification to produce rAAV commercial …
Jan 9, 2023 · Viralgen is now licensed for the commercial manufacturing of recombinant adeno-associated virus (rAAV) gene therapies up to 2,000 liters and has completed seven successful …See details»
Viragen International Inc - Company Profile and News
Viragen International, Inc. researches, develops, and manufactures products designed to help the human immune system resist viral infections, and related technologies. The Company …See details»
Cipla-Ubio Biotech launch RT-PCR test kit ViraGen in India
May 20, 2021 · ViraGen is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology. It helps to identify and detect …See details»
Interferon-alpha Omniferon - Viragen - AdisInsight - Springer
29 Jun 2001 Viragen has received UK approval to begin clinical trials with OmniferonTM for the treatment of multiple sclerosis 09 Feb 2001 Pall Corporation will supply leukocytes fo Viragen …See details»
Cipla launches RT-PCR test kit ‘ViraGen’ in ... - The Indian Express
May 20, 2021 · Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated. The company will commence supply of the …See details»
Cipla's COVID-19 testing kit ViraGen to be available from
May 25, 2021 · In a breakthrough, Indian pharmaceutical giant Cipla launched a real-time COVID-19 testing kit last week. The RT-PCR test device called 'ViraGen' will be available in the …See details»